Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 8056 to 8070 of 8150 results

  1. Ovarian cancer patients to have NICE-approved drug combination option on Cancer Drugs Fund

    A potentially life-extending drug combination for some people with advanced, high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer will now be available on the Cancer Drugs Fund (CDF), following its approval by NICE in draft guidance published today.

  2. Over 500 people a year can access a new life extending lung cancer treatment after NICE recommends its use within the Cancer Drugs Fund

    An innovative life-extending drug for treating mutation-positive locally advanced or metastatic non-small-cell lung cancer (NSCLC) in adults is being recommended by NICE as an option for use within the Cancer Drugs Fund.

  3. Over 600 people set to benefit from innovative lung cancer treatment within the Cancer Drugs Fund

    More than 600 people could benefit from an innovative drug for a form of lung cancer as NICE publishes final draft guidance recommending osimertinib within the Cancer Drugs Fund.

  4. Over 700 people a year could benefit from a new potentially life-extending lung cancer drug which targets a specific genetic mutation

    New potentially life-extending lung cancer drug which targets a specific genetic mutation recommended by NICE

  5. Overuse of painkillers can make headaches worse

    Taking medicines such as painkillers over a prolonged period of time to relieve headaches can actually make symptoms worse, according to latest guidelines from NICE.

  6. Patients should be more involved in decisions about their care, says NICE

    A new collaborative, made up of the UK’s leading health care organisations including NICE, has set out plans that will help get patients more involved in decisions about their care.

  7. Patients with blood clots should be treated within 4 hours, says NICE

    People who present to hospital with blood clots in the legs or lungs should be offered treatment within 4 hours and have their investigative tests including scans within 24 hours, according to latest guidelines.

  8. Patients with rare bile duct cancer set to benefit from life extending treatment

    Some people who have a rare form of bile duct cancer are set to benefit from life-extending treatment

  9. Patients with rare blood disorders to receive new treatment option, says NICE

    Hundreds of people with two rare blood disorders will soon have access to a new treatment regimen following guidance from NICE.

  10. Shared decision making is an integral part of healthcare, says NICE

    Shared decision making between patients and clinicians should be embedded throughout healthcare services, says NICE, in draft guidance published today.

  11. Shared decision making underpins good healthcare

    Shared decision making between service users and healthcare professionals is an integral part of healthcare, says NICE, in new guideline recommendations published today.

  12. Simple blood test for pneumonia can help limit use of antibiotics

    Using the C-reactive protein blood test can help GPs determine whether a person with a chest infection has pneumonia and should be treated with antibiotics, NICE says.

  13. Small, practical steps are best way of maintaining a healthy weight

    Limiting screen time, walking more, and eating healthily are among the most effective ways of maintaining a healthy weight and preventing excess weight gain.

  14. South Tyneside wins first NICE Local Government Chronicle Public Health Award

    South Tyneside Metropolitan Borough Council (MBC) has been named the winner of the first Local Government Chronicle (LGC) Public Health Award sponsored by NICE.

  15. Statins could be a choice for more people to reduce their risk of heart attacks and strokes, says NICE

    New evidence on the safety of statins means more people could benefit from them, new NICE draft guidance says.